Drug Type Small molecule drug |
Synonyms (1,2-dihydroxy-3-propyl)thiophyllin, (±)-7-(2,3-dihydroxypropyl)theophylline, (±)-diprophylline + [19] |
Action antagonists, inhibitors |
Mechanism Adenosine receptor antagonists, Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs) inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (07 Mar 1951), |
Regulation- |
Molecular FormulaC10H14N4O4 |
InChIKeyKSCFJBIXMNOVSH-UHFFFAOYSA-N |
CAS Registry479-18-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00691 | Dyphylline |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Asthmatic bronchitis | China | 01 Jan 1996 | |
| Asthma | United States | 07 Mar 1951 | |
| Bronchial Spasm | United States | 07 Mar 1951 | |
| Pulmonary Disease, Chronic Obstructive | United States | 07 Mar 1951 |





